Extended spectrum β-lactamase producing enterobacteriaceae in lebanese ICU patients: Epidemiology and patterns of resistance

Journal of General and Applied Microbiology

Volumn 52, Issue 3, 2006, Pages 169-178

  Daoud, Ziad ^a,b   Moubareck, Carole ^c   Hakime, Noha ^a   Doucet Populaire, Florence ^c  

^a SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^b UNIVERSITY OF BALAMAND   (Lebanon)

^c Institute of Anatomy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENERAL HOSPITAL; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LEBANON; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; TERTIARY HEALTH CARE; TREND STUDY; BIOSYNTHESIS; CLINICAL TRIAL; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; FECES; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CASE-CONTROL STUDIES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HUMANS; INTENSIVE CARE UNITS; LEBANON; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33750105661     PISSN: 00221260     EISSN: 13498037     Source Type: Journal    
DOI: 10.2323/jgam.52.169     Document Type: Article

References (28)

1. Araj, G. F. (1999) Antimicrobial resistance in Lebanon. APUA Newsletter, 1, 14.
2. Babini, G. S. and Livermore, D. M. (2000) Antimicrobial resistance amongst Klebsiella spp. Collected from intensive care units in Southern and Western Europe in 1997-1998. J. Antimicrob. Chemother., 45, 183-189.
3. Bonnet, R. (2004) Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob. Agents Chemother., 48, 114.
4. Bradford, P. A. (2001) Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol., 14, 933-951.
5. Bradford, P. A., Cherubin, C. E., Idemyor, V., Ramussen, B. A., and Bush, K. (1994) Multiply resistant Klebsiella pneumoniae strains from two Chicago Hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidimehydrolyzing β-lactamases in a single isolate. Antimicrob. Agents Chemother., 38, 761-766
6. Bush, K., Jacoby, G. A., and Medeiros, A. A. (1995) A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 39, 1211-1233
7. D'Agata, E. M., Venkataraman, L., DeGirolami, P., et al. (1999) Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak period: Prevalence, risk factors, and rate of infection. Crit. Care Med., 27, 1090-1095.
8. Daoud, Z. and Hakime, N. (2003) Prevalence and susceptibility patterns of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev. Esp. Quimioter., 16, 233-238.
9. Daoud, Z., Hakime, N. I., Hamze, M., Mangeney, N., Matta, H., Mokhbat, J. E., Rohban, R., Sarkis, D. K., Doucet-Populaire, F., and Moubareck, C. (2005) Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J. Clin. Microbiol., 43: 3309-3313.
10. Hacek, D. M., Bednarz, P., Noskin, G. A., Zembower, T, and Peterson, L. R. (2001) Yield of vancomycin-resistant Enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. J. Clin. Microbiol., 39, 1152-1154.
11. Ho, P. L., for the Hong Kong Intensive Care Unit Antimicrobial Resistance Study (HK-ICARE) Group. (2003) Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant Enterococci before and after intensive care unit admission. Crit. Care Med., 31, 1175-1182.
12. Itokazu, G. S., Quinn, J. P., Bell-Dixon, C., Kahan, F. M., and Weinstein, R. A. (1996) Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program. Clin. Infect. Dis., 23, 779-784.
13. Jarlier, V., Nicolas, M. H., Fournier, G., and Philippon, A. (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect Dis., 10, 867-878.
14. Jarlier, V., Nicolas, M., Fournier, G., and Philippon, A. (1998) Extended broad-spectrum β-lactamases conferring transferable resistance to never β-lactam agents in Enetrobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10, 867-878.
15. Kaye, K. S., Engemann, J. J., Fraimow, H. S., and Abrutyn, E. (2004) Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and management. Infect Dis. Clin. N. Am., 18, 467-511.
16. Cormican, M. G., Marshall, S. A., and Jones, R. N. (1996) Detection of extended-spectrum β-lactamases (ESBL)-producing strains by the Etest ESBL Screen. J. Clin. Microb., 34, 1880-1884.
17. Masterton, R. G. (2000) Surveillance studies: How can they help the management of infection? J. Antimicrob. Chemother., 46 (Suppl. T2), 53-58.
18. Merrer, J., Santoli, F., Appere-de-Vecchi, C., et al. (2000) "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect. Control Hosp. Epidemiol., 21, 718-723.
19. Monnet, D. L. (2000) Toward multinational antimicrobial resistance surveillance systems in Europe. Int. J. Antimicrob. Agents, 15, 91-101.
20. Mulvey, M. R., Bryce, E., Boyd, D., Ofner-Agostini, M., Christianson, S., Simor, A. E., and Paton, S. (2004) Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother., 8, 1204-1214.
21. Munday, C. J., Whitehead, G. M., Todd, N. J., Campbell, M., and Hawkey, P. M. (2004a) Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J. Antimicrob. Chemother., 54, 628-633.
22. Munday, C. J., Xiong, J., Li, C., Shen, D., and Hawkey, P. M. (2004b) Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J. Antimicrob. Agents, 23, 175-180.
23. National Nosocomial Infections Surveillance (NNIS) System Report (2003) Data summary from January 1992 through June 2003, issued August 2003. Am. J. Infect Control, 31, 481-498.
24. NCCLS (2000) Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th ed., Approved Standard M100-S9, National Committee for Clinical Laboratory Standards, Wayne, PA.
25. Nseir, S., Di Pompeo, C., Soubrier, S., Delour, P., Lenci, H., Roussel-Delvallez, M., Onimus, T., Saulnier, F., Mathieu, D., and Durocher, A. (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit. Care Med., 33-42.
26. Pitout, J. D. D., Sanders, C. C., and Sanders, W. E. (1997) Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli. Am. J. Med., 103, 51-59.
27. Toltzis, P., Yamashita, T., Vilt, L., et al. (1997) Colonization with antibiotic-resistant Gram-negative organisms in a pediatric intensive care unit. Crit. Care Med., 25, 538-544.
28. Waterer, G. W. and Wunderink, R. G. (2001) Increasing threat of Gram-negative bacteria. Crit. Care Med., 29, N75-N81.